5 ms·

Aspirin may increase rates of some cancers. https://discover.dc.nihr.ac.uk/content/signal-000696/aspirin-did-not-prevent-deaths-or-disability-in-healthy-older-

by DanBC 7y ago

Aspirin may increase rates of some cancers. https://discover.dc.nihr.ac.uk/content/signal-000696/aspirin-did-not-prevent-deaths-or-disability-in-healthy-older-adults https://discover.dc.nihr.ac.uk/content/signal-000696/aspirin... > In the ASPREE trial, older adults with no apparent cardiovascular disease who took daily aspirin saw no benefit in terms of reducing the chance of dying or having dementia or disability. Instead, it slightly increased their mortality and bleeding risk - aspirin was associated with an excess of 1.6 deaths per 1,000 people per year. Half of these deaths were due to cancer. (Although this is at odds with other research and so we need to be careful when interpreting it).

brer 7y ago
Interesting, but you highlight the major reproducibility crisis of many scientific studies (along with others that have resulted from unfettered money and politics contaminating modern research). https://www.youtube.com/watch?v=LfHEuWaPh9Q https://www.youtube.com/watch?v=LfHEuWaPh9Q
Barrin92 7y ago
maybe this brings up a general question. If the effects of aspirin are so complex and interact with so many different forms of complications and benefits, is it even sensible to make a recommendation based on individual factors? Is maybe some other methodology preferable, like aggregating all the negatives and positives and just make a sort of statistical recommendation?